Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology - WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME

This article continues a series of reports updating recent research developments of particular interest to personnel involved in the treatment and management of patients with heart failure. This is a summary of selected presentations made at the Scientific Sessions of the XXIII Annual Congress of th...

Full description

Saved in:
Bibliographic Details
Published in:European journal of heart failure 2001-12, Vol.3 (6), p.747-750
Main Authors: Coletta, Alison P., Cleland, John G.F.
Format: Article
Language:English
Subjects:
Anticoagulants - therapeutic use
Aspirin - therapeutic use
cardiology
Cardiovascular Diseases - drug therapy
Clinical Trials, Phase II as Topic
Electric Countershock
ESCAMI
Europe
Guanidines - therapeutic use
heart failure
Humans
PAFAC
Pyridines - therapeutic use
Randomized Controlled Trials as Topic
RITZ-I
Sulfones - therapeutic use
Tetrazoles - therapeutic use
TIME
Vasodilator Agents - therapeutic use
Warfarin - therapeutic use
WARIS II
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This article continues a series of reports updating recent research developments of particular interest to personnel involved in the treatment and management of patients with heart failure. This is a summary of selected presentations made at the Scientific Sessions of the XXIII Annual Congress of the European Society of Cardiology. Summaries of the following clinical studies are included: WARIS-II, ESCAMI, PAFAC, RITZ-I and TIME.
ISSN:1388-9842
1879-0844
DOI:10.1016/S1388-9842(01)00210-0